Global sustainable outcomes - News & Views Q1 2020

Global sustainable outcomes – News & Views Q1 2020

This quarter has marked the end of the longest bull market in history after a decade-long recovery since the global financial crisis. Entering 2020, nobody would have predicted the “black swan” event that was to come, providing a lethal shot to both the financial markets and global economies.

Since a new SARS-(severe acute respiratory syndrome) related virus was first reported in Wuhan in December under the name SARS-CoV-2, it has dominated global headlines. Although markets have recovered from the initial sell-off, which was the fastest in history, uncertainty remains both in terms of the path of the virus and that of economic recovery.

The Global Sustainable Outcomes (GSO) strategy has navigated this crisis well, benefiting from our focus on quality companies with solid environmental, social and governance (ESG) credentials and financial liquidity. This saw the strategy falling -14.7% vs the MSCI World decline of -21.3% from 31 December 2019-31 March 2020 – an 8.3% outperformance.1

More importantly, several of our investments made a strong impact during this crisis. The largest sustainable theme within GSO is that of health, wellbeing and food security, accounting for roughly 27% of our holdings. This pandemic has served to highlight the importance of medical innovation and good health.

Medical technology has accelerated in recent years and this has been clearly on display during this crisis with the rapid progress made with both the development of vaccines as well as therapeutic treatments targeting the virus. The genome of the disease was mapped by mid-January and there are 70+ vaccine programmes underway. In the past this would have taken years not weeks to achieve.

Several of our healthcare holdings2 have made a positive contribution, including:

  • Gilead (a world leader in antiviral/antiinflammatory medicines): its specialist skills in developing anti-viral drugs means it has a key role to play in developing treatments for new viruses such as Covid-19. Gilead’s CEO also said any potential treatment would be affordable and accessible to all.
  • Thermo Fisher Scientific (the world leader in serving medical science): it developed a key diagnostic test to detect nucleic acid from SARSCoV- 2. Its products were also used by scientists to find evidence that the virus is genetically stable and therefore a good target for a vaccine.
Covid-19 has also served to highlight the importance of strong governmentfunded healthcare systems which provide quality healthcare to all. This is particularly relevant in the US which has huge inequality in its healthcare provision, which could widen further as unemployment rises. This supports the expansion of US Medicaid, a federal and state programme that helps with medical costs for the elderly, disabled and those with low incomes.

A core holding in the strategy, Centene, is the leading Medicaid-managed care provider and will play a vital role in expanding this programme to the broader population. Technology has also played a key role during this pandemic. With lockdown, employees are forced to work from home. Large cloud platform providers have had to meet the surge in demand for their services. A core holding in the strategy, Microsoft, has successfully done so, and not just for office workers but also students. My children have been successfully using Microsoft teams to conduct online lessons with their teachers and co-ordinate their learning. Governments have also been using such services to share Covid-19 dashboards with citizens and have provided key support to critical health and safety organisations such as first responders.

Improved levels of hygiene, meanwhile, have been critical in helping to slow the spread of Covid-19. Two of our holdings have played a key role here:

  • Ecolab is a leading microbial control expert whose hygiene and sanitation solutions for commmercial companies are key in supporting hygienic and healthy environments. Its solutions have helped ensure the enviroment for workers in essential services is clean and sanitary.
  • SGS SA is an industrial inspection, testing and analysis services company. It is offering the services of its network of experts in health and safety, hygiene, disinfection monitoring, emergency planning, training and hazardous waste management to support businesses navigating this crisis.
20 May 2020
Pauline Grange and Jess Williams
Pauline Grange & Jess Williams
Portfolio Manager, Global Equities & Portfolio Analyst, Responsible Investment
Share article
Share on linkedin
Share on email
Key topics
Related topics
Listen on Stitcher badge
Share article
Share on linkedin
Share on email
Key topics
Related topics


Global sustainable outcomes – News & Views Q1 2020

1 Columbia Threadneedle Investments, 1 April 2020.

2 Mention of specific stocks is not a recommendation to deal.

Related Insights

4 December 2023

Steven Bell

Chief Economist, EMEA

Unemployment is now the key to US rate cuts

Will rising unemployment mean the Federal Reserve cuts rates sooner rather than later? Steven Bell explains why we’re watching upcoming US data closely.
Watch time - 5 min
1 December 2023

Claudia Wearmouth

Managing Director, Co-Head, Responsible Investment

Greater clarity and a focus on financial outcomes

There are plenty of macro drivers that will create equity volatility in 2024. To succeed, investors will need to maintain a resilient portfolio.
Read time - 4 min
27 November 2023

Steven Bell

Chief Economist, EMEA

UK base rate cuts to be delayed following last week's Autumn Statement

The UK’s Autumn Statement partially relieved the upward trend in taxes. But what does that mean for interest rates? Steven Bell explains why cuts in early 2024 now seem unlikely.
Watch time - 5 min

You may also like

Investment approach

Teamwork defines us and is fundamental to our investment approach, which is structured to facilitate the generation, assessment and implementation of good, strong investment ideas for our portfolios.

Funds and Prices

Columbia Threadneedle Investments has a comprehensive range of investment funds catering for a broad range of objectives.

Our Capabilities

We offer a broad range of actively managed investment strategies and solutions covering global, regional and domestic markets and asset classes.